Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

HSCS

HeartSciences Inc

2.56

Jul 14 • 05:33AM ET -0.08 (-3.14%)

Healthcare Medical Devices USA Nano NASD

Peers: VTAK NVNO ICCM IRIX TNON AEMD INBS NUWE SINT FEED

| Held by: VXF

Scroll to Statements

Index	-
Market Cap	8.42M
Enterprise Value	8.89M
Income	-8.49M
Sales	0.01M
Book/sh	0.83
Cash/sh	1.03
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	15
IPO	Jun 15, 2022

P/E	-
Forward P/E	-
PEG	-
P/S	841.74
P/B	3.07
P/C	2.48
P/FCF	-
EV/EBITDA	-
EV/Sales	888.74
Quick Ratio	0.85
Current Ratio	1.00
Debt/Eq	1.46
LT Debt/Eq	0.24
Option/Short	No / Yes

EPS (ttm)	-4.93
EPS next Y	-2.55
EPS next Q	-0.66
EPS this Y	62.51%
EPS next Y	26.51%
EPS next 5Y	40.70%
EPS past 3/5Y	-73.91% 24.72%
Sales past 3/5Y	-32.86% -41.63%
EPS Y/Y TTM	51.71%
Sales Y/Y TTM	-41.03%
EPS Q/Q	75.59%
Sales Q/Q	-
Earnings	Mar 12
EPS/Sales Surpr.	19.32% -

Insider Own	23.25%
Insider Trans	0.00%
Inst Own	6.55%
Inst Trans	0.07%
ROA	-128.00%
ROE	-382.32%
ROIC	-258.26%
Gross Margin	-1425.63%
Oper. Margin	-89939.57%
Profit Margin	-97880.97%
SMA20	1.50%
SMA50	18.59%
SMA200	-4.18%
Trades

Shs Outstand	3.18M
Shs Float	2.53M
Short Float	4.89%
Short Ratio	0.05
Short Interest	0.12M
52W High	4.39 -41.75%
52W Low	1.63 56.88%
Volatility	8.24% 13.66%
ATR (14)	0.28
RSI (14)	52.77
Beta	1.77
Rel Volume	0.02
Avg Volume	2.30M
Volume	2,142

Perf Week	-11.21%
Perf Month	36.02%
Perf Quarter	28.50%
Perf Half Y	-22.04%
Perf YTD	-17.24%
Perf Year	-41.21%
Perf 3Y	-97.31%
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	12.00
Prev Close	2.64
Price	2.56
Change	-3.14%

Jun-23-26 03:56PM	Zcash Miner Fortitude Merging with HeartSciences to Go Public (Ipo Edge) +55.37%
07:30AM	Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets (Business Wire)
Jun-11-26 08:30AM	European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences' Patent Portfolio to More Than 45 Granted Patents (GlobeNewswire)
Jun-02-26 08:30AM	HeartSciences Launches MyoVista Insights Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm (GlobeNewswire)
May-19-26 08:30AM	HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network (GlobeNewswire)
09:00AM	Loading…
May-05-26 09:00AM	HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights (GlobeNewswire)
Apr-14-26 04:15PM	HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting (GlobeNewswire)
Mar-25-26 08:30AM	HeartSciences' MyoVista Insights Receives Epic Toolbox Designation for ECG Management System Category (GlobeNewswire)
Mar-24-26 11:18AM	HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings (GlobeNewswire)
Mar-16-26 04:15PM	HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update (GlobeNewswire)
Feb-05-26 08:30AM	University of West England Adopts HeartSciences' MyoVista Insights Platform and MyoVista wavECG Device to Establish ECG Education and Technology Reference Center (GlobeNewswire)
Jan-29-26 08:30AM	Cibolo Health Designates HeartSciences' MyoVista Insights as Endorsed ECG Management Platform for Network of 123 Independent Hospitals (GlobeNewswire)
Dec-15-25 04:15PM	HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update (GlobeNewswire) -6.48%
08:30AM	HeartSciences Announces FDA 510(k) Submission for MyoVista wavECG Device (GlobeNewswire)
Dec-11-25 08:30AM	HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 (GlobeNewswire)
09:55AM	Loading…
Oct-21-25 09:55AM	HeartSciences Inc. (HSCS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
Sep-11-25 04:15PM	HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results (GlobeNewswire) -10.03%
Aug-15-25 09:00AM	HeartSciences Announces Conference Participation and Investor Webinar (GlobeNewswire)
Jul-24-25 04:15PM	HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results (GlobeNewswire)
Jun-05-25 09:06AM	HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithm (TipRanks) -5.03%
Jun-04-25 09:00AM	HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis (GlobeNewswire)
Jun-03-25 09:00AM	Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences' Patent Portfolio and IP Value (GlobeNewswire) +6.78%
May-30-25 09:05AM	HeartSciences signs first MyoVista Insights platform customer (TipRanks)
May-29-25 09:00AM	HeartSciences Signs First MyoVista Insights Platform Customer, Marking Major Commercial Milestone (GlobeNewswire)
May-20-25 09:00AM	HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025 (GlobeNewswire) +21.68%
07:00AM	Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream (GlobeNewswire)
May-08-25 09:00AM	HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson (GlobeNewswire)
May-07-25 09:00AM	HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board (GlobeNewswire)
May-01-25 09:00AM	HeartSciences Announces Launch of MyoVista Insights Platform and Related Early Adopter Program (GlobeNewswire)
Mar-13-25 04:15PM	HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results (GlobeNewswire)
09:00AM	Loading…
Mar-10-25 09:00AM	HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications (GlobeNewswire)
Dec-16-24 04:15PM	HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results (GlobeNewswire)
Nov-13-24 09:00AM	HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement (GlobeNewswire)
Oct-14-24 04:15PM	HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire) +5.92% -5.03%
Sep-12-24 04:15PM	HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results (GlobeNewswire) +8.96%
09:00AM	HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission (GlobeNewswire)
Jul-29-24 04:05PM	HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results (GlobeNewswire) -10.26% -6.81%
Jul-26-24 09:00AM	Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista wavECG Potential to Improve Cardiovascular Pathway Efficiency (GlobeNewswire) +22.13%
Jul-25-24 08:30AM	HeartSciences Selected to Demonstrate MyoVista wavECG at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare (GlobeNewswire)
Jul-11-24 09:00AM	HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction (GlobeNewswire) -8.60%
Jun-04-24 04:15PM	HeartSciences Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire) -9.49% +7.77%
May-20-24 09:00AM	HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio (GlobeNewswire) -15.64%
May-13-24 07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -19.77%
Apr-24-24 09:00AM	HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG (GlobeNewswire) +9.10%
Apr-02-24 04:15PM	HeartSciences to Present at the LD Micro Invitational XIV Conference (GlobeNewswire) -6.09%
Mar-26-24 09:00AM	HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients (GlobeNewswire)
Mar-14-24 09:54PM	HSCS Stock Earnings: Heart Test Laboratories Beats EPS for Q3 2024 (InvestorPlace) +5.75%
04:15PM	HeartSciences Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Mar-12-24 09:00AM	HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes (GlobeNewswire)
Mar-06-24 09:20AM	Why Is Heart Test Laboratories (HSCS) Stock Down 21% Today? (InvestorPlace) -27.41%
09:00AM	HeartSciences Announces Canada Patent Grant Covering MyoVista Wavelet Technology (GlobeNewswire)
Feb-26-24 09:00AM	HeartSciences Adds Key Advisor to its Scientific Advisory Board (GlobeNewswire)
Feb-12-24 09:00AM	HeartSciences Expands its Scientific Advisory Board (GlobeNewswire)
Feb-01-24 09:00AM	HeartSciences Appoints New Scientific Advisory Board Member (GlobeNewswire) -5.87%
Jan-18-24 08:00AM	HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting (GlobeNewswire) -17.05%
Jan-03-24 04:15PM	HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting (GlobeNewswire) -6.31%
Dec-18-23 11:52AM	HSCS Stock Earnings: Heart Test Laboratories Misses EPS for Q2 2024 (InvestorPlace) -8.24%
Dec-14-23 04:15PM	HeartSciences Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire) +12.09%
Dec-05-23 08:00AM	HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway (GlobeNewswire)
Nov-20-23 08:00AM	HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms (GlobeNewswire) +11.65%
Nov-15-23 08:07AM	Why Is Heart Test Laboratories (HSCS) Stock Up 43% Today? (InvestorPlace) -16.62%
Nov-13-23 08:45AM	HeartSciences' MyoVista wavECGTM Selected for Heart Screening of Irish Garda National Police Officers (GlobeNewswire)
Nov-08-23 07:54AM	Why Is Heart Test Laboratories (HSCS) Stock Up 298% Today? (InvestorPlace) +53.38%
Oct-19-23 09:00AM	HeartSciences Issues Investor Update Highlighting Recent Key Achievements and Positive Developments (GlobeNewswire)
Sep-26-23 08:00AM	HeartSciences Receives Two New Patent Allowances, Expanding its International Patent Portfolio (GlobeNewswire)
Sep-25-23 08:00AM	HeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I. (GlobeNewswire) -6.57%
Sep-21-23 08:00AM	HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms (GlobeNewswire)
Sep-14-23 04:15PM	HeartSciences Reports First Quarter Fiscal 2024 Financial Results (GlobeNewswire)
Sep-12-23 04:15PM	HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase (GlobeNewswire)
Sep-11-23 04:15PM	HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards (GlobeNewswire)
Sep-07-23 09:00AM	HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India (GlobeNewswire)
Aug-31-23 09:00AM	HeartSciences Signs Distribution Agreement with FJ Medical, Denmark (GlobeNewswire)
Aug-24-23 09:00AM	HeartSciences MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation (GlobeNewswire)
Aug-17-23 10:36AM	EXCLUSIVE: HeartSciences Announces Expansion of Artificial Intelligence Patent Portfolio (Benzinga)
09:00AM	HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio (GlobeNewswire)
Jul-27-23 09:00AM	MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark (GlobeNewswire)
Jul-19-23 09:00AM	HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results (GlobeNewswire) -5.26%
May-17-23 08:00AM	HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine (GlobeNewswire)
May-09-23 08:15AM	HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG (GlobeNewswire)
May-08-23 08:15AM	HeartSciences to Participate at the Inaugural EF Hutton Global Conference (GlobeNewswire)
May-02-23 08:15AM	HeartSciences to Participate in The Benchmark Companys Virtual Individual Investor Healthcare Conference (GlobeNewswire)
Apr-24-23 09:00AM	Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV (ACCESSWIRE) -10.11%
Apr-17-23 08:15AM	HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023 (GlobeNewswire) +9.10%
Mar-18-23 08:39AM	Heart Test Laboratories Reports Third Quarter 2023 Earnings (Simply Wall St.)
Mar-16-23 04:15PM	HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results (GlobeNewswire) -8.18% +9.90%
Feb-07-23 11:04AM	HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time (GlobeNewswire)
Feb-06-23 07:30AM	HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease (GlobeNewswire) -17.65%
Feb-03-23 09:00AM	HeartSciences Announces Further Internationalization of its Patent Portfolio (GlobeNewswire) +139.44%
Jan-24-23 11:00AM	Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET (GlobeNewswire)
Jan-23-23 09:00AM	Correction: HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th (GlobeNewswire)
Jan-20-23 09:00AM	HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th (GlobeNewswire)
Jan-04-23 09:00AM	HeartSciences Appoints David R. Wells to its Board of Directors, an Experienced Capital Markets and Finance Executive (GlobeNewswire)
Dec-16-22 08:30AM	HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results (GlobeNewswire)
Dec-01-22 09:00AM	HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms (GlobeNewswire)
Nov-28-22 09:00AM	HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022 (GlobeNewswire) -5.76%
Nov-21-22 09:00AM	HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 (GlobeNewswire)
Nov-10-22 09:00AM	HeartSciences MyoVista® Technology Used to Develop AI-ECG Algorithm to Identify Patients at High-Risk of Major Adverse Cardiovascular Events (GlobeNewswire)
Oct-25-22 09:00AM	HeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista® ECG (GlobeNewswire) +14.02%
Oct-20-22 09:00AM	HeartSciences Named as a Top 10 MedTech Startup 2022 by MedTech Outlook Magazine (GlobeNewswire) +10.13%
Oct-19-22 09:15AM	HeartSciences Announces Major Milestone with the Issuance of CPT® Codes by the American Medical Association for ECG AI Analysis of Cardiac Dysfunction (GlobeNewswire)

HeartSciences, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. The firm offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded on August 16, 2007 and is headquartered in Southlake, TX.

CEOMr. Andrew Simpson

CFO & TreasurerMs. Danielle Watson

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HILZ MARK T	COO, Secretary and Director	Jul 29 '25	Sale	3.54	4,416	15,621	4,752	Jul 30 09:00 PM
HILZ MARK T	Officer	Jul 29 '25	Proposed Sale	3.56	4,416	15,721		Jul 29 10:21 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HSCS

HeartSciences Inc

Upgrade your Finviz experience